Zobrazeno 1 - 10
of 381
pro vyhledávání: '"Pieters, Rob"'
Autor:
Brigitha LJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; and.; Pediatric Oncology and Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Zaky K; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; and., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; and., van der Sluis IM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; and.
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2024 Aug 13. Date of Electronic Publication: 2024 Aug 13.
Autor:
Thus KA; Princess Máxima Center for Pediatric Oncology, Utrecht., De Groot-Kruseman HA; Princess Máxima Center for Pediatric Oncology, Utrecht., Winkler-Seinstra P; Princess Máxima Center for Pediatric Oncology, Utrecht., Fiocco M; Mathematical Institute Leiden University, Leiden University, Leiden, The Netherlands; Department of Biomedical Data Science, Section Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht., Segers H; Department of Pediatric Hemato-Oncology, University Hospitals Leuven, Leuven, Belgium., Van den Bos C; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Amsterdam, the Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht., Van der Sluis IM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht., Tissing WJE; Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht., Veening MA; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht., Zwaan CM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht., Van Tilburg CM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; National Center for Tumor diseases (NCT), Heidelberg., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht., Bierings M; Princess Máxima Center for Pediatric Oncology, Utrecht. m.b.bierings-2@prinsesmaximacentrum.nl.
Publikováno v:
Haematologica [Haematologica] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.
Autor:
Lopez-Millan B; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Rubio-Gayarre A; Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Vinyoles M; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Trincado JL; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Fraga MF; CINN-ISPA, Oviedo, Spain., Fernandez-Fuentes N; Josep Carreras Leukemia Research Institute., Barcelona, Spain., Guerrero-Murillo M; Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Martinez-Moreno A; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine,, Barcelona, Spain., Velasco-Hernandez T; Josep Carreras Leukemia Research Institute., Barcelona, Spain., Falgàs A; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Panisello C; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Valcarcel G; Josep Carreras Leukemia Research Institute, Badalona, Spain., Sardina JL; Josep Carreras Leukaemia Research Institute, Badalona, Spain., López-Martí P; Josep Carreras Leukaemia Research Institute, Badalona, Spain., Javierre BM; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain., Del Valle-Pérez B; Programa de Recerca en Cancer. Hospital del Mar Research Institute (IMIM) and Department of Medicine and Life Science. Universitat Pompeu Fabra, Barcelona, Spain., García de Herreros A; Hospital del Mar Research Institute, Barcelona, Spain., Locatelli F; Bambino Gesù Children's Hospital, Catholic University of Sacred Heart, Rome, Italy., Pieters R; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Bardini M; Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Cazzaniga G; Fondazione Tettamanti, Monza, Italy., Rodríguez-Manzaneque JC; GENYO. Center for Genomics and Oncological Research: Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain., Hanewald T; Goethe-University of Frankfurt/Main, Frankfurt, Germany., Marschalek R; Goethe-University of Frankfurt/Main, Frankfurt, Germany., Milne TA; University of Oxford, Oxford, United Kingdom., Stam RW; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Tejedor JRR; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Oviedo, Spain., Menendez P; Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Bueno C; Josep Carreras Leukemia Research Institute, Barcelona, Spain.
Publikováno v:
Blood [Blood] 2024 Aug 02. Date of Electronic Publication: 2024 Aug 02.
Autor:
Conter V; Pediatrics and Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza., Valsecchi MG; Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; School of Medicine and Surgery, University of Milano-Bicocca., De Lorenzo P; Pediatrics and Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza., Gandemer V; Department of Pediatric Hemato-Oncology, University Hospital of Rennes, Rennes., Heyman M; Department of Paediatric Oncology, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm., Saha V; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata., Diaz P; Chilean National Pediatric Oncology Group, Santiago, Chile; Hospital Dr. Gustavo Fricke, Vina del Mar, Chile., Li CK; The Chinese University of Hong Kong, Hong Kong Children's Hospital., Attarbaschi A; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria; St. Anna Children's Cancer Research Institute, Vienna., Escherich G; University Medical Centre Hamburg-Eppendorf, Clinic of Paediatric Haematology and Oncology, Hamburg., Stary J; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Schrappe M; University Medical Center Schleswig-Holstein, Pediatrics, Campus Kiel, Kiel., Pieters R; Princess Maxima Center for Pediatric Oncology, Utrecht., Cario G; University Medical Center Schleswig-Holstein, Pediatrics, Campus Kiel, Kiel., Biondi A; Pediatrics and Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; School of Medicine and Surgery, University of Milano-Bicocca. abiondi.unimib@gmail.com.
Publikováno v:
Haematologica [Haematologica] 2024 Jul 18. Date of Electronic Publication: 2024 Jul 18.
Autor:
Peirelinck H; Belgian Cancer Registry, Brussels, Belgium., Schulpen M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hoogendijk R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Van Damme A; Department of Pediatric Hematology and Oncology, Saint Luc University Hospital, Brussels, Belgium., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Utrecht, Utrecht, The Netherlands., Henau K; Belgian Cancer Registry, Brussels, Belgium., Van Damme N; Belgian Cancer Registry, Brussels, Belgium., Karim-Kos HE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Jul 15; Vol. 155 (2), pp. 226-239. Date of Electronic Publication: 2024 Mar 13.
Autor:
Lecornec N; Department of Pediatric Hematology and Immunology, Hôpital Universitaire Robert Debré, AP-HP and Université Paris-Cité, Paris, France., Fahd M; Department of Pediatric Hematology and Immunology, Hôpital Universitaire Robert Debré, AP-HP and Université Paris-Cité, Paris, France., De Lorenzo P; Pediatrics and Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Valsecchi MG; Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy., Micalizzi C; Clinical Experimental Haematology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy., Diaz P; Hospital Gustavo Fricke, Pediatrics, Viña del Mar, Chile., Pennella C; Department of Hematology-Oncology, Hospital de Pediatría S.A.M.I.C. 'Prof. Dr. Juan P. Garrahan', Buenos Aires, Argentina., Locatelli F; Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy., Vinti L; Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy., Cavé H; Department of Genetics, Hôpital Universitaire Robert Debré, AP-HP and Université Paris-Cité, Paris, France., Caye-Eude A; Department of Genetics, Hôpital Universitaire Robert Debré, AP-HP and Université Paris-Cité, Paris, France., Stary J; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Pieters R; Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Baruchel A; Department of Pediatric Hematology and Immunology, Hôpital Universitaire Robert Debré, AP-HP and Université Paris-Cité, Paris, France., Brethon B; Department of Pediatric Hematology and Immunology, Hôpital Universitaire Robert Debré, AP-HP and Université Paris-Cité, Paris, France.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jul 09. Date of Electronic Publication: 2024 Jul 09.
Autor:
Moorman AV; Leukaemia Research Cytogenetics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK. anthony.moorman@newcastle.ac.uk., Enshaei A; Leukaemia Research Cytogenetics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Murdy D; Leukaemia Research Cytogenetics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Joy M; Leukaemia Research Cytogenetics Group, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Haas V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Horstmann MA; Research Institute Children's Cancer Center Hamburg, Hamburg and Department of Pediatric Oncology and Hematology, University Medical Center, 20246, Hamburg, Germany., Escherich G; Research Institute Children's Cancer Center Hamburg, Hamburg and Department of Pediatric Oncology and Hematology, University Medical Center, 20246, Hamburg, Germany., Johansson B; Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden.; Department of Clinical Genetics and Pathology and Molecular Diagnostics, Laboratory Medicine, Region Skåne, Lund, Sweden., Marquart HV; Department of Clinical Immunology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Schmiegelow K; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Paediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark., Hancock J; Bristol Genetics Laboratory, North Bristol NHS Trust, Bristol, UK., Moppett J; Department of Haematology, Bristol Children's Hospital, Bristol, UK., Heyman M; Astrid Lindgren Children's Hospital, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Leukemia [Leukemia] 2024 Jul 05. Date of Electronic Publication: 2024 Jul 05.
Autor:
van Kalsbeek RJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. R.J.vanKalsbeek@prinsesmaximacentrum.nl., Hudson MM; St. Jude Children's Research Hospital, Memphis, TN, USA., Mulder RL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Ehrhardt M; St. Jude Children's Research Hospital, Memphis, TN, USA., Green DM; St. Jude Children's Research Hospital, Memphis, TN, USA., Mulrooney DA; St. Jude Children's Research Hospital, Memphis, TN, USA., Hakkert J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., den Hartogh J; Dutch Childhood Cancer Organization (Vereniging Kinderkanker Nederland), De Bilt, The Netherlands., Nijenhuis A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, Utrecht Medical Center, Utrecht, the Netherlands., Schouten-van Meeteren AYN; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Tinteren H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Verbruggen LC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Conklin HM; St. Jude Children's Research Hospital, Memphis, TN, USA., Jacola LM; St. Jude Children's Research Hospital, Memphis, TN, USA., Webster RT; St. Jude Children's Research Hospital, Memphis, TN, USA., Partanen M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kollen WJW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Grootenhuis MA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Faculty of Medicine, Utrecht University and Utrecht Medical Center, Utrecht, the Netherlands.
Publikováno v:
Nature medicine [Nat Med] 2024 Jul; Vol. 30 (7), pp. 2091.
Autor:
Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. malieva@iib.uam.es.; Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain. malieva@iib.uam.es., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Petcu D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Dautzenberg NMM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., van de Ven C; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., Calkoen FGJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Clevers H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, the Netherlands.; Pharma, Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kuball J; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands.; Department of Hematology, UMC Utrecht, Utrecht University, Utrecht, the Netherlands., Sebestyén Z; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
Nature protocols [Nat Protoc] 2024 Jul; Vol. 19 (7), pp. 2052-2084. Date of Electronic Publication: 2024 Mar 19.
Autor:
Østergaard A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Fiocco M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Mathematical Institute, Leiden University, Leiden, The Netherlands.; Department of Biomedical Science, Section Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands., de Groot-Kruseman H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands., Moorman AV; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; United Kingdom Acute Lymphoblastic Leukaemia (UKALL) study group, Liverpool, UK., Vora A; United Kingdom Acute Lymphoblastic Leukaemia (UKALL) study group, Liverpool, UK.; Department of Haematology, Great Ormond Street Hospital, London, UK., Zimmermann M; Department of Paediatric Haematology and Oncology, Hannover Medical School, 30625, Hannover, Germany.; Berlin-Frankfurt-Münster Study Group (BFM), Frankfurt, Germany., Schrappe M; Berlin-Frankfurt-Münster Study Group (BFM), Frankfurt, Germany.; Department of Paediatrics, University Medical Centre Schleswig-Holstein, Kiel, Germany., Biondi A; Department of Pediatrics, University of Milano-Bicocca, Monza, Italy.; Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP), Bologna, Italy., Escherich G; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Childhood Acute Lymphoblastic Leukemia study group (CoALL), Hamburg, Germany., Stary J; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic., Imai C; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.; Children's Cancer and Leukemia Study Group (CCLSG), Nagoya, Japan., Imamura T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.; Japan Childhood Leukemia Study Group (JACLS), Nagoya, Japan., Heyman M; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Paediatric Oncology, Karolinska University Hospital, Stockholm, Sweden.; Nordic Society of Paediatric Haematology and Oncology (NOPHO), Nordic Countries, Uppsala, Sweden., Schmiegelow K; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.; Nordic Society of Paediatric Haematology and Oncology (NOPHO), Nordic and Baltic Countries, Uppsala, Sweden., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. r.pieters@prinsesmaximacentrum.nl.; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands. r.pieters@prinsesmaximacentrum.nl.
Publikováno v:
Leukemia [Leukemia] 2024 Jul; Vol. 38 (7), pp. 1477-1487. Date of Electronic Publication: 2024 Jun 06.